GlassScriptPhysician profile
William J Kopp
NPI 1285604371
$5,054.10
in general payments reported to CMS, 2019-2025
32 companies · $94.06 in 2025
The $94.06 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $591 · 2021: $1,084 · 2022: $952 · 2023: $887 · 2024: $982 · 2025: $94.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,962.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $997.92 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $969.24 | 2019-2025 | |
| Novo Nordisk INC | $514.69 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $456.29 | 2019-2024 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $345.80 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $282.97 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.53 | 2020-2024 | Jardiance |
| Allergan, INC. | $163.60 | 2019-2020 | |
| Amarin Pharma, INC. | $159.63 | 2019-2022 | |
| Abbott Laboratories | $122.52 | 2021-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $64.41 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $63.74 | 2021-2024 | Rexulti |
| Amgen INC. | $61.28 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $60.93 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $58.92 | 2023-2024 | Cologuard Collection Kit |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $56.36 | 2024-2025 | Auvelity |
| Daiichi Sankyo INC. | $54.37 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $51.08 | 2019-2024 | |
| Boston Scientific Corporation | $49.64 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Takeda Pharmaceuticals U.S.A., INC. | $44.75 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $38.03 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $37.92 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.74 | 2022 | |
| Endo Pharmaceuticals INC. | $28.86 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $28.55 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.88 | 2021 | |
| Merck Sharp & Dohme LLC | $17.66 | 2023 | Dificid |
| Shield Therapeutics INC | $14.69 | 2023 | Accrufer |
| Alfasigma USA, INC. | $13.63 | 2020 | |
| Astellas Pharma US INC | $13.61 | 2024 | Veozah |
| Horizon Therapeutics Plc | $13.29 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.